Detalhe da pesquisa
1.
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nat Immunol;
23(9): 1379-1392, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36002648
2.
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.
J Transl Med;
16(1): 129, 2018 05 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29769125
3.
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
J Cell Physiol;
232(8): 2246-2252, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27987320
4.
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
BMC Cancer;
17(1): 101, 2017 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28166748
5.
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
J Cell Physiol;
231(11): 2541-7, 2016 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27187274
6.
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
Breast Cancer Res Treat;
148(1): 73-80, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25238881
7.
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
J Exp Clin Cancer Res;
43(1): 75, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38459559
8.
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
Int J Cancer;
132(5): 1022-31, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22847294
9.
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.
Breast Cancer Res Treat;
133(3): 949-58, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22094935
10.
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available.
J Clin Pathol;
75(12): 844-850, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34400544
11.
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Cancers (Basel);
14(12)2022 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35740637
12.
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
Cancers (Basel);
14(19)2022 Oct 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36230758
13.
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.
Cell Death Differ;
28(5): 1493-1511, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33230261
14.
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Sci Rep;
11(1): 13770, 2021 07 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34215766
15.
High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.
J Clin Invest;
117(3): 693-702, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17290307
16.
Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas.
BMC Cancer;
10: 151, 2010 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20403162
17.
p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.
Clin Breast Cancer;
20(6): e761-e770, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32580907
18.
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
Ther Adv Med Oncol;
11: 1758835919853192, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31452691
19.
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.
Breast Cancer Res;
10(5): R74, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18771580
20.
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
J Exp Clin Cancer Res;
37(1): 95, 2018 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29716630